The Valley Desk

NCT04069936 · Interventional trial

Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

Overall registry status Terminated

Phase 2

Conditions Lung Cancer, Lung Cancer Metastatic, Lung Cancer, Non-small Cell, NSCLC, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer, Non-small Cell Lung Cancer Metastatic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov